{"log_id": 5239283479349772559, "direction": 0, "words_result_num": 32, "words_result": [{"probability": {"variance": 5e-06, "average": 0.998595, "min": 0.99476}, "location": {"width": 100, "top": 166, "height": 31, "left": 241}, "words": "毒理研究"}, {"probability": {"variance": 0, "average": 0.999651, "min": 0.999082}, "location": {"width": 97, "top": 215, "height": 29, "left": 239}, "words": "遗传毒性"}, {"probability": {"variance": 1.2e-05, "average": 0.998061, "min": 0.982675}, "location": {"width": 769, "top": 262, "height": 61, "left": 284}, "words": "体内外的诱变研究均未发现重组人Ⅱ型肿瘤坏死因子受体抗体融合蛋白具"}, {"probability": {"variance": 5e-06, "average": 0.998491, "min": 0.992677}, "location": {"width": 243, "top": 308, "height": 40, "left": 234}, "words": "有诱导遗传突变的活性"}, {"probability": {"variance": 1e-06, "average": 0.999209, "min": 0.997761}, "location": {"width": 97, "top": 358, "height": 30, "left": 232}, "words": "生殖毒性"}, {"probability": {"variance": 0.0001, "average": 0.996955, "min": 0.957694}, "location": {"width": 780, "top": 406, "height": 62, "left": 276}, "words": "在大鼠和家兔中进行的发育毒性研究中未发现重组人Ⅱ型肿瘤坏死因子受"}, {"probability": {"variance": 5e-06, "average": 0.998524, "min": 0.990631}, "location": {"width": 595, "top": 452, "height": 55, "left": 227}, "words": "体抗体融合蛋白(人用剂量的60~100倍)对胎仔的损害"}, {"probability": {"variance": 1e-06, "average": 0.99894, "min": 0.996931}, "location": {"width": 155, "top": 500, "height": 36, "left": 233}, "words": "【药代动力学】"}, {"probability": {"variance": 3e-06, "average": 0.999073, "min": 0.991495}, "location": {"width": 778, "top": 548, "height": 65, "left": 269}, "words": "据国外文献报道,本品的血清浓度以 ELISA方法测定,该方法可以检测出"}, {"probability": {"variance": 4e-06, "average": 0.998823, "min": 0.991515}, "location": {"width": 414, "top": 596, "height": 46, "left": 222}, "words": "与 ELISA反应的降解产物及其原型成分"}, {"probability": {"variance": 2e-06, "average": 0.998611, "min": 0.997258}, "location": {"width": 50, "top": 646, "height": 26, "left": 218}, "words": "吸收"}, {"probability": {"variance": 0.009422, "average": 0.971424, "min": 0.553104}, "location": {"width": 829, "top": 690, "height": 67, "left": 263}, "words": "本品从皮下注射的部位缓慢吸收,在单次剂量后约48小时达峰值浓度。绝900"}, {"probability": {"variance": 0.010745, "average": 0.952839, "min": 0.652036}, "location": {"width": 827, "top": 734, "height": 70, "left": 212}, "words": "对生物利用度为76%。在每周两次剂量情况不,预期稳态浓度约为单次剂量后欢"}, {"probability": {"variance": 0.000556, "average": 0.992227, "min": 0.894619}, "location": {"width": 828, "top": 783, "height": 67, "left": 209}, "words": "察值的两倍。单次皮下注射25mg本品后健康志愿者中测得的平均血清峰值浓"}, {"probability": {"variance": 0.014615, "average": 0.909233, "min": 0.542595}, "location": {"width": 944, "top": 825, "height": 97, "left": 208}, "words": "度为1.65±0.6gml,曲线下面积为296 ug, hr/mi.50mg本品每周一次"}, {"probability": {"variance": 2.7e-05, "average": 0.99731, "min": 0.981015}, "location": {"width": 255, "top": 881, "height": 42, "left": 257}, "words": "21)和25mg本品每周"}, {"probability": {"variance": 0.018342, "average": 0.936934, "min": 0.463076}, "location": {"width": 531, "top": 886, "height": 67, "left": 564}, "words": "n16)治疗的类风湿关节炎患者中的稳透每"}, {"probability": {"variance": 0.030332, "average": 0.904634, "min": 0.369467}, "location": {"width": 831, "top": 921, "height": 75, "left": 202}, "words": "均血清浓度情况为:Cm别为4mg/和2.6mg:cCm分别为12mg/和1.4"}, {"probability": {"variance": 0.001711, "average": 0.983468, "min": 0.846951}, "location": {"width": 251, "top": 977, "height": 38, "left": 205}, "words": "mg/;部分AUC分别为"}, {"probability": {"variance": 0.014024, "average": 0.962284, "min": 0.408638}, "location": {"width": 509, "top": 990, "height": 48, "left": 521}, "words": "h/和316mgh/l在健康志愿者的开放、单剂、2"}, {"probability": {"variance": 0.010421, "average": 0.965056, "min": 0.444004}, "location": {"width": 831, "top": 1017, "height": 73, "left": 197}, "words": "种治疗、交叉试验>本品单剂50mg/ml注射与三支25mgml同时注射是生物"}, {"probability": {"variance": 0, "average": 0.999698, "min": 0.99936}, "location": {"width": 74, "top": 1071, "height": 29, "left": 199}, "words": "等效的"}, {"probability": {"variance": 3.6e-05, "average": 0.997827, "min": 0.965243}, "location": {"width": 780, "top": 1120, "height": 60, "left": 244}, "words": "在一项强直性脊柱炎患者的群体药代动力学分析中,50mg本品每周一次"}, {"probability": {"variance": 0.00725, "average": 0.968804, "min": 0.532204}, "location": {"width": 817, "top": 1165, "height": 66, "left": 203}, "words": "(N=154)和25mg每周二次(N=148),本品稳态AUC分别为466ug.hr/ml"}, {"probability": {"variance": 1e-06, "average": 0.998433, "min": 0.996674}, "location": {"width": 68, "top": 1214, "height": 25, "left": 192}, "words": "和474"}, {"probability": {"variance": 0.059634, "average": 0.818376, "min": 0.436481}, "location": {"width": 78, "top": 1223, "height": 22, "left": 266}, "words": "g.hml"}, {"probability": {"variance": 0, "average": 0.999926, "min": 0.999883}, "location": {"width": 54, "top": 1261, "height": 30, "left": 189}, "words": "分布"}, {"probability": {"variance": 0.000535, "average": 0.993167, "min": 0.867124}, "location": {"width": 778, "top": 1308, "height": 64, "left": 236}, "words": "本品的浓度时间曲线为双指数曲线。本品的分布体积中间值为7.6L,而稳"}, {"probability": {"variance": 0.008054, "average": 0.967818, "min": 0.685004}, "location": {"width": 216, "top": 1354, "height": 42, "left": 184}, "words": "态分布体积为10.4L"}, {"probability": {"variance": 0, "average": 0.999573, "min": 0.999185}, "location": {"width": 55, "top": 1404, "height": 31, "left": 181}, "words": "清除"}, {"probability": {"variance": 2e-06, "average": 0.998982, "min": 0.994461}, "location": {"width": 777, "top": 1452, "height": 61, "left": 231}, "words": "本品从体内清除缓慢。半衰期长,约70小时。类风湿关节炎患者的清除率"}, {"probability": {"variance": 0.002896, "average": 0.97664, "min": 0.720907}, "location": {"width": 828, "top": 1497, "height": 64, "left": 176}, "words": "约为0.066L/hr,比健康志愿者中的观察值0.hr略低。此外,本品的药代动"}], "language": 3}